nach oben

Current Atherosclerosis Reports

Erschienen in:

01.12.2011 | Nutrition (William S. Harris, Section Editor)

Dietary Guidelines for Americans 2010: Implications for Cardiovascular Disease

verfasst von: Michael R. Flock, Penny M. Kris-Etherton

Erschienen in: Current Atherosclerosis Reports | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

The 2010 Dietary Guidelines for Americans (DGA) provides science-based advice to promote health and reduce risk of major chronic diseases by diet and physical activity. The primary emphasis is on food-based recommendations that meet energy and nutrient needs. The DGA is made in the context of a total diet designed to reduce the incidence and prevalence of overweight and obesity. In addition, the DGA also targets cardiovascular disease (CVD) risk reduction. DGA recommends nutrient-dense foods including fruits and vegetables, whole grains, low-fat dairy, lean protein foods including seafood, and vegetable oils. This dietary pattern beneficially affects blood lipids and other CVD risk factors. Foods and nutrients to limit include solid fats (saturated fatty acids, trans-fatty acids), dietary cholesterol, added sugars, refined grains, and sodium. Healthy dietary patterns that emphasize nutrient-dense foods will significantly benefit public health, in part, by reducing CVD risk.

U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2010 7th Edition. Washington, DC: US Government Printing Office, 2010.

Jacobs Jr DR, Gallaher DD. Whole grain intake and cardiovascular disease: a review. Curr Atheroscler Rep. 2004;6:415–23.PubMedCrossRef

Dauchet L, Amouyel P, Dallongeville J. Fruits, vegetables and coronary heart disease. Nat Rev Cardiol. 2009;6:599–608.PubMedCrossRef

Van Horn L, McCoin M, Kris-Etherton PM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc. 2008;108:287–331.PubMedCrossRef

Kelly SA, Summerbell CD, Brynes A, et al. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev. 2007;CD005051.

Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716–31.PubMedCrossRef

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Interim final rule. Fed Regist. 2002;67:61773–83.

Harris K, Kris-Etherton P. Effects of whole grains on coronary heart disease risk. Curr Atheroscler Rep. 2010;12:368–76.PubMedCrossRef

10.

Tholstrup T, Hoy CE, Andersen LN, et al. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently? J Am Coll Nutr. 2004;23:169–76.PubMed

11.

Kris-Etherton PM, Grieger JA, Hilpert KF, West SG. Milk products, dietary patterns and blood pressure management. J Am Coll Nutr. 2009;28 Suppl 1:103S–19S.PubMed

12.

Zemel MB. Mechanisms of dairy modulation of adiposity. J Nutr. 2003;133:252S–6S.PubMed

13.

Ross AC, Manson JE, Abrams SA, et al. The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J Am Diet Assoc. 2011;111:524–7.PubMedCrossRef

14.

Nadir MA, Szwejkowski BR, Witham MD. Vitamin D and cardiovascular prevention. Cardiovasc Ther. 2010;28:e5–e12.PubMedCrossRef

15.

Beauchesne-Rondeau E, Gascon A, Bergeron J, Jacques H. Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am J Clin Nutr. 2003;77:587–93.PubMed

16.

Davidson MH, Hunninghake D, Maki KC, et al. Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med. 1999;159:1331–8.PubMedCrossRef

17.

Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271–83.PubMedCrossRef

18.

• Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613. This special report by the AHA sets the goal of improving cardiovascular health of all Americans by 20% while reducing deaths from CVD and stroke by 20%. PubMedCrossRef

19.

Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist. 1999;64:57700–33.

20.

Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276–82.PubMedCrossRef

21.

• Jenkins DJ, Mirrahimi A, Srichaikul K, et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr. 2010;140:2302S–11S. The different types of soy protein influences serum cholesterol reduction is a novel finding in this analysis. PubMedCrossRef

22.

Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr. 2006;96 Suppl 2:S68–78.PubMedCrossRef

23.

Mukuddem-Petersen J, Oosthuizen W, Jerling JC. A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr. 2005;135:2082–9.PubMed

24.

• Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821–7. This review of intervention trials identifies the benefits of nut intake on blood lipid levels and what factors modify the effects. PubMedCrossRef

25.

Ros E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr. 2009;89:1649S–56S.PubMedCrossRef

26.

•• Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–99. This is an excellent review of randomized controlled trials and large prospective studies assessing the benefits and risks of fish or fish oil intake. PubMedCrossRef

27.

Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493–9.PubMedCrossRef

28.

Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19–30.PubMedCrossRef

29.

Mozaffarian D, Geelen A, Brouwer IA, et al. Effect of fish oil on heart rate in humans. Circulation. 2005;112:1945–52.PubMedCrossRef

30.

Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S–54S.PubMed

31.

Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother. 2008;9:1237–48.PubMedCrossRef

32.

Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–57.PubMedCrossRef

33.

Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292–333.PubMedCrossRef

34.

Mozaffarian D, Shi P, Morris JS, et al. Mercury exposure and risk of cardiovascular disease in two U.S. cohorts. N Engl J Med. 2011;364:1116–25.PubMedCrossRef

35.

Harris W, Kris-Etherton P, Harris K. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008;10:503–9.PubMedCrossRef

36.

Burr ML. Secondary prevention of CHD in UK men: the diet and reinfarction trial and its sequel. Proc Nutr Soc. 2007;66:9–15.PubMedCrossRef

37.

• Mozaffarian D, Micha R, Wallace S: Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252. This is a detailed review of randomized controlled trials assessing the cardiovascular benefit of replacing SFA with PUFA in the diet. PubMedCrossRef

38.

Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911–9.PubMedCrossRef

39.

•• Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab. 2009;55:173–201. This comprehensive review thoroughly examines different fatty acids and coronary heart disease in both epidmiologic and clinical studies. It provides an up-to-date analysis of the association between different fatty acids and coronary heart disease events and/or mortality. PubMedCrossRef

40.

Brouwer IA, Wanders AJ, Katan MB. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans–a quantitative review. PLoS One. 2010;5:e9434.PubMedCrossRef

41.

Berglund L, Lefevre M, Ginsberg HN, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611–20.PubMed

42.

Judd JT, Baer DJ, Clevidence BA, et al. Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men. Lipids. 2002;37:123–31.PubMedCrossRef

43.

Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69.PubMedCrossRef

44.

Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med. 1995;24:308–15.PubMedCrossRef

45.

• Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91:535–46. This meta-analsis of prospective studies challenges the connection between SFA and CVD risk, reporting that no association exists between SFA and CVD risk. PubMedCrossRef

46.

Jakobsen MU, O’Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425–32.PubMedCrossRef

47.

Rudel LL, Parks JS, Sawyer JK. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:2101–10.PubMedCrossRef

48.

Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002;102:1621–30.PubMedCrossRef

49.

Dietary Guidelines Advisory Committee, 2010 Report. Available from: http://www.cnpp.usda.gov/DGAs2010-DGACReport.htm.

50.

Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington D.C.: Institute of Medicine; 2005.

51.

Strazzullo P, D’Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339.

52.

Institute of Medicine Strategies to Reduce Sodium Intake in the United States. Washington, DC: Institute of Medicine, 2010.

53.

Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24.PubMedCrossRef

54.

Hansel B, Thomas F, Pannier B, et al. Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? Eur J Clin Nutr. 2010;64:561–8.PubMedCrossRef

Titel: Dietary Guidelines for Americans 2010: Implications for Cardiovascular Disease
verfasst von: Michael R. Flock
Penny M. Kris-Etherton
Publikationsdatum: 01.12.2011
Verlag: Current Science Inc.
Erschienen in: Current Atherosclerosis Reports / Ausgabe 6/2011
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-011-0205-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2011

Dietary Nitrates, Nitrites, and Cardiovascular Disease

Protein and Coronary Heart Disease: The Role of Different Protein Sources

Erratum to: Resveratrol in the Prevention and Treatment of Coronary Artery Disease

Effects of Dietary Factors on Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)

Resveratrol in the Prevention and Treatment of Coronary Artery Disease